---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-127560"
form_type: "8-K"
ticker: "ACET"
cik: "0001720580"
company_name: "Adicet Bio, Inc."
filed_at: "2024-11-15T23:59:59+00:00"
generated_at: "2026-05-29T23:50:11.077036+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Adicet Bio amends loan agreement to remove Adicet Shanghai shares from collateral, allow $500K transfers

## Summary
- Eighth Amendment to loan with Banc of California (formerly Pacific Western Bank) dated Nov 8, 2024.
- Equity interests in Adicet Shanghai removed from pledged collateral; no security interest on those shares.
- Permitted investment threshold for cash transfers to Adicet Shanghai increased to $500,000 without bank approval.
- Other amendments include deletion of Success Fee provisions and update of bank name to Banc of California.

## SEC filing metadata
- accession: 0000950170-24-127560
- form_type: 8-K
- ticker: ACET
- cik: 0001720580
- company_name: Adicet Bio, Inc.
- filed_at: 2024-11-15T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1720580/000095017024127560/0000950170-24-127560-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1720580/000095017024127560/acet-20241108.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-127560
- JSON: https://secwatch.observer/filing/0000950170-24-127560.json
- Plain text: https://secwatch.observer/filing/0000950170-24-127560.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.